Molecular analysis in X-linked adrenoleukodystrophy patients: identification of a novel mutation


DURMAZ A. , ATİK T. , ONAY H. , CANDA E. E. , Ucar S. K. , BADEMKIRAN F. , ...More

METABOLIC BRAIN DISEASE, vol.29, no.3, pp.809-812, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 3
  • Publication Date: 2014
  • Doi Number: 10.1007/s11011-014-9552-1
  • Title of Journal : METABOLIC BRAIN DISEASE
  • Page Numbers: pp.809-812

Abstract

X linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disease characterized by progressive demyelination of the central nervous system, adrenocortical insufficiency and elevated levels of very long chain fatty acids (VLCFAs). It is caused by mutations in ABCD1 gene located at Xq28. More than 1,300 mutations have been identified to date which is unique to each patient. In this study we report the mutational analysis of 2 X-ALD patients (1 male and 1 female) showing variable clinical spectrum. The mutation analysis of the female patient revealed IVS5-6delC (c.1489-6delC) and p. P543L variations in compound heterozygous state. The male patient was found to be hemizygous for a novel mutation, p. R104P. In conclusion, while defining a novel mutation, the cases presented herein may contribute to the mutation and clinical spectrum of X-ALD.